Home/Filings/4/0000891293-13-000015
4//SEC Filing

BENNER STEVEN E 4

Accession 0000891293-13-000015

CIK 0000891293other

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 5:53 PM ET

Size

8.7 KB

Accession

0000891293-13-000015

Insider Transaction Report

Form 4
Period: 2013-03-21
BENNER STEVEN E
EVP, Chief Medical Officer
Transactions
  • Award

    Common Stock

    2013-03-21+296,705363,371 total
  • Award

    Performance Rights

    2013-03-21+253,438253,438 total
    Exercise: $0.00Exp: 2015-12-31Common Stock (253,438 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    33,334
Footnotes (2)
  • [F1]This transaction represents a grant by CTIC of restricted stock. The grant is scheduled to vest as to one-third of the shares on the dates that are six months, 12 months and 18 months after the date of grant.
  • [F2]This transaction represents a grant of performance-based restricted stock units pursuant to CTIC's long-term incentive program. The reporting person has been granted an award that is payable in shares of CTIC common stock upon the achievement of certain performance goals on or before December 31, 2015. Should such a goal be timely achieved, the number of shares payable will be determined by multiplying the payout percentage that has been assigned by CTIC to that goal multiplied by the number of shares of CTIC common stock issued and outstanding at the time that particular goal has been achieved. One such performance goal is the attainment by CTIC of a specified level of market capitalization. The units reported above reflect the 0.225% payout percentage that has been assigned by CTIC to this market capitalization goal for purposes of the reporting person's award multiplied by the number of shares of CTIC common stock issued and outstanding as of March 21, 2013.

Issuer

CELL THERAPEUTICS INC

CIK 0000891293

Entity typeother

Related Parties

1
  • filerCIK 0001242117

Filing Metadata

Form type
4
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 5:53 PM ET
Size
8.7 KB